The next evolution of veterinary medicine delivery. Nanos leverages proprietary sublingual technology to redefine therapeutic bioavailability.

Strips dissolve on contact with saliva and gently adhere to the oral mucosa.
Active molecules cross oral mucosal tissues into systemic circulation.
Avoids stomach acids and first-pass liver metabolism that degrade traditional pills.
Traditional pills must survive the harsh environment of the digestive tract, where stomach acids and liver enzymes can significantly reduce how much of a medication ever reaches the bloodstream.
Nanostrip delivers active ingredients through the highly vascularized oral mucosa—bypassing digestion and enabling faster, more efficient absorption with lower, more precise doses.
“By utilizing the highly vascularized oral mucosa, Nanos ensures maximum bioavailability with lower, more precise doses.”
— DVM Research Advisory Board
Measurable performance across all therapeutic indicators.
Time to therapeutic concentration
Uncompromising quality control at every stage of synthesis.
Independent laboratory verification for purity and potency.
Purely synthesized molecules without genetic modification.
Ingredients that meet official pharmacopeia standards.
Produced in cGMP compliant, inspected facilities.
Join the community of pet clinicians and parents leading the molecular revolution in pet care.